Tirzepatide 10mg

Tirzepatide Sodium is a synthetic research peptide used to investigate dual receptor signalling involving glucose‑dependent insulinotropic polypeptide (GIP) and glucagon‑like peptide‑1 (GLP‑1). Its distinct sequence and structure make it a key tool in metabolic and biochemical studies examining peptide–receptor interactions and mechanisms of metabolic regulation.

Product details

• Amino acid sequence: YE-Aib-GTFSDYSI-Aib-LDKIAQ (C20 fatty acid) AFVQWLIAGGPSSGAPPPS

• Non‑standard residue: Aib (α‑aminoisobutyric acid), a non‑coded amino acid with the structure H₂H‑C(CH₃)₂‑COOH

• Molecular formula: C₂₂₅H₃₄₈N₄₈O₆₈

• Molecular weight: 4813.527 g/mol

• PubChem CID: 156588324

• CAS number: 2023788‑19‑2

Research applications

• Incretin signalling: Employed in experimental models as a dual GIP/GLP‑1 receptor agonist to explore laboratory mechanisms of glucose and lipid metabolism.

• Peptide–receptor studies: Its engineered structure supports detailed analysis of receptor binding, activation, and downstream signalling in non‑clinical systems.

Usage and safety
Tirzepatide Sodium is supplied strictly for laboratory research use and is not approved for human or veterinary applications. Appropriate laboratory safety procedures, including the use of personal protective equipment and compliant handling practices, should be followed at all times.

Disclaimer
This information is provided for educational and scientific research purposes only. The material is not intended to diagnose, treat, cure, or prevent any disease and must not be used for human consumption.